# Genenta Science S.p.A.: Form 20-F for the period ended Dec 31, 2022

- Company: [Genenta Science S.p.A.](/companies/gnta.md) (CIK 1838716)
- Form: 20-F
- Filed: 2023-04-21
- Accepted by EDGAR: Apr 21, 2023, 17:21 ET
- Period: 2022-12-31
- Accession: 0001493152-23-013272
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1838716/000149315223013272/form20-f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1838716/000149315223013272/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 12 months, 2022-01-01 to 2022-12-31 | EUR 5.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2022-01-01 to 2022-12-31 | −EUR 11.0m | us-gaap:OperatingIncomeLoss |
| Net income | 12 months, 2022-01-01 to 2022-12-31 | −EUR 8.5m | us-gaap:NetIncomeLoss |
| Basic EPS | 12 months, 2022-01-01 to 2022-12-31 | −EUR 0.47 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 12 months, 2022-01-01 to 2022-12-31 | −EUR 7.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2022-01-01 to 2022-12-31 | EUR 27.1k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2022-12-31 | EUR 4.0k | us-gaap:Cash |
| Current assets | at 2022-12-31 | EUR 31.7m | us-gaap:AssetsCurrent |
| Total assets | at 2022-12-31 | EUR 33.4m | us-gaap:Assets |
| Current liabilities | at 2022-12-31 | EUR 2.2m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2022-12-31 | EUR 31.1m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2022-12-31 | 18,216,858 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1838716/000149315223013272/form20-f.htm

Filed Apr 21, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-013272. Last ingested by Listed: Nov 2, 2026, 06:07 ET. No prices; not investment advice.